Drug-tracking measure obtains House panel OK

05/16/2013 | Hill, The

A House panel approved along party lines a measure that would strengthen the tracking of prescription treatments. The FDA will be required to propose new regulations to protect consumers from counterfeit prescriptions by 2027, but the measure does not require that those rules be put into effect.

View Full Article in:

Hill, The

Published in Briefs: